D-0055-2025 Class II Ongoing
FDA drug recall D-0055-2025 was initiated by Noven Pharmaceuticals Inc on Oct 31, 2024 and is designated Class II. Reason for recall: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive). The recall status is ongoing. Affected quantity: 685 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 27, 2024
- Initiation Date
- Oct 31, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 685 boxes
Product description
Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3
Reason for recall
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Distribution pattern
USA nationwide.
Code information
Lot # 95598, Exp 02/28/25
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0055-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026